Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease
Background: Type 2 diabetes mellitus (T2DM) are 90% of diabetes cases, and its prevalence and incidence, including comorbidities, are rising worldwide. Clinically, diabetes and associated comorbidities are identified by biochemical and physical characteristics including glycemia, glycated hemoglobin...
Saved in:
Main Authors: | Symeon Savvopoulos, Haralampos Hatzikirou, Herbert F Jelinek |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-02-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/11772719231222111 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to “Comparative Analysis of Biomarkers in Type 2 Diabetes Patients With and Without Comorbidities: Insights Into the Role of Hypertension and Cardiovascular Disease”
Published: (2025-02-01) -
Hypertension, diabetes, and cardiovascular disease nexus: investigating the role of urbanization and lifestyle in Cabo Verde
by: Aaron Kobina Christian, et al.
Published: (2024-12-01) -
Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients
by: Zhengwen Xu, et al.
Published: (2025-02-01) -
Arduous management in treatment of elderly patient with pulmonary arterial hypertension and cardiopulmonary comorbidities
by: Yu Enomoto, et al.
Published: (2025-01-01) -
Comparison Of ALT In Type 2 Diabetics with And Without Fatty Liver Disease
by: Kausar Malik, et al.
Published: (2023-06-01)